We are live on
!
Find out more
EAM
EULAV Asset Management Portfolio holdings
AUM
$3.13B
1-Year Est. Return
23.04%
This Fund
S&P 500
This Quarter
Est. Return
+8.65%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.68B
AUM Growth
+$147M
(+5.8%)
Cap. Flow
-$35.9M
Cap. Flow
% of AUM
-1.34%
Top 10 Holdings %
Top 10 Hldgs %
23.74%
Holding
195
New
2
Increased
35
Reduced
62
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$20.5M |
| 2 |
HEICO Corp
HEI
|
+$15.4M |
| 3 |
W.R. Berkley
WRB
|
+$12M |
| 4 |
WCN
Waste Connections
WCN
|
+$10.3M |
| 5 |
Gartner
IT
|
+$7.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$23.3M |
| 2 |
Intuit
INTU
|
+$20.6M |
| 3 |
Accenture
ACN
|
+$13.9M |
| 4 |
ServiceNow
NOW
|
+$12M |
| 5 |
Cadence Design Systems
CDNS
|
+$9.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.59% |
| 2 | Industrials | 21.71% |
| 3 | Healthcare | 15.27% |
| 4 | Financials | 13.4% |
| 5 | Consumer Discretionary | 6.93% |
Similar funds
LFG
BI
GKWIM
DIG
BP
CCI
PC
TCG
EULAV Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, EULAV Asset Management held 195 positions worth $2.68B, up 5.8% from $2.54B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
EULAV Asset Management's Q2 2023 filing shows 2 new, 35 increased, 62 reduced and 9 closed positions. Its largest new stake was Getty Images: 400,000 shares worth $1.95M. The largest sale was S&P Global, an estimated $23.3M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Industrials and Healthcare.
- EULAV Asset Management's largest Q2 2023 buy was Getty Images: 400,000 shares worth $1.95M.
- EULAV Asset Management added most to West Pharmaceutical in Q2 2023, an estimated $20.5M increase.
- EULAV Asset Management's biggest Q2 2023 reduction was S&P Global, cutting an estimated $23.3M.
- EULAV Asset Management fully exited Bio-Rad Laboratories Class A in Q2 2023, selling an estimated $6.51M.
- EULAV Asset Management's ten largest holdings make up 24% of its $2.68B portfolio in Q2 2023.
- EULAV Asset Management opened 2 new positions and closed 9 in Q2 2023.
- EULAV Asset Management's portfolio value rose 5.8% quarter-over-quarter to $2.68B.
Based on EULAV Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.